tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

BSXBoston Scientific

Health care · Medical Instruments · NYSE

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. 10-K, Item 1

Employees
59,000
Headquarters
Marlborough, MA
CEO
Michael F. Mahoney
Next results
around Feb 3, 2027
Compare with peers → Embed

What the debt is made of, and when it is due

balance sheet of Sep 30, 2026 · schedule of Dec 31, 2025
Debt: $12.0B Debt$12.0B Long-term debt: $10.9B · 91% Long-term debt$10.9B · 91% Short-term debt: $1.0B · 9% Short-term debt$1.0B · 9% Year 2: $1.1B · 9% Year 2$1.1B · 9% Year 3: $1.2B · 10% Year 3$1.2B · 10% Year 4: $1.2B · 10% Year 4$1.2B · 10% Year 5: $1.2B · 10% Year 5$1.2B · 10% After year 5: $6.5B · 54% After year 5$6.5B · 54%

The debt note's own lines, 2025-12-31

Line, as the company names itKindRateFixed or floatingAmount
Senior NotesTotal of the lines–not stated$11.3B
March 2032 Euro Senior NotesNotes and bonds3.50%not stated$1.5B
June 2030 NotesNotes and bonds2.65%not stated$1.2B
December 2027 NotesNotes and bonds0.62%not stated$1.1B
March 2031 Notes 2Notes and bonds3.00%not stated$999.0M
November 2019 Aggregate Offering––not stated$900.0M
March 2028 Senior NotesNotes and bonds1.38%not stated$881.0M
March 2029 Euro Senior NotesNotes and bonds3.38%not stated$881.0M
March 2031 NotesNotes and bonds1.62%not stated$881.0M
March 2034 Notes 2Notes and bonds3.25%not stated$764.0M
March 2049 NotesNotes and bonds4.70%not stated$650.0M
March 2034 NotesNotes and bonds1.88%not stated$588.0M
March 2039 NotesNotes and bonds4.55%not stated$450.0M
November 2035 NotesNotes and bonds6.25%not stated$350.0M
March 2028 NotesNotes and bonds4.00%not stated$344.0M
January 2040 NotesNotes and bonds7.38%not stated$300.0M
March 2029 NotesNotes and bonds4.00%not stated$272.0M
Finance Lease Obligation––not stated$125.0M
All 18 lines

From the debt note in the 10-K's XBRL (0000885725-26-000010), as the company tags it: by issue, by year, by currency or by kind. Lines from two ways of cutting the same debt can overlap, so they are not added up. Fixed or floating is read from the line's own name only; "not stated" when it says neither.

Left: the debt lines on the balance sheet (XBRL). Right: the principal due each year, from the debt note's maturity schedule; it can differ a little from the balance sheet, which shows the debt net of discounts and fees. Leases are not counted.

When BSX has to repay the principal of its long-term debt, from the debt note of the 10-K filed Feb 17, 2026 (balance sheet of Dec 31, 2025). Fiscal years are counted from that date.

Due within 5 years
$4.6B
of $11.1B scheduled
Principal due by fiscal year, with cash on hand as a line Year 2: $1.1B (LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo) $1.1B FY2027 Year 2 Year 3: $1.2B (LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree) $1.2B FY2028 Year 4: $1.2B (LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour) $1.2B FY2029 Year 5: $1.2B (LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive) $1.2B FY2030 After year 5: $6.5B (LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive) $6.5B Later after year 5 Cash today $2.0B
Each bar is the principal due in that fiscal year. The dashed line is the cash on the same balance sheet: a bar above it is a year the company could not repay from today's cash alone.
WhenPrincipal dueShare
Year 2 FY2027 $1.1B 10%
Year 3 FY2028 $1.2B 11%
Year 4 FY2029 $1.2B 10%
Year 5 FY2030 $1.2B 11%
After year 5 $6.5B 58%

Principal only: interest, leases and commercial paper are not in this schedule. Hover a row for its XBRL line. Open the filing ↗

Work on BSX in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/BSX/export.csv") into a cell.